Literature DB >> 15944563

Total tympanic membrane reconstruction: AlloDerm versus temporalis fascia.

Andrew J Fishman1, Michelle S Marrinan, Tina C Huang, Seth J Kanowitz.   

Abstract

BACKGROUND AND
OBJECTIVE: Patients who require surgery for chronic otitis media with perforation and cholesteatoma frequently provide no residual tympanic membrane that is usable in grafting procedures. A novel technique of total tympanic membrane reconstruction (TTMR) is described that maximizes perforation closure rate in these situations while minimizing mucosalization, incomplete healing, and anterior blunting. The specific aim of this report is to assess the safety and efficacy of TTMR and to compare the results obtained with AlloDerm compared with temporalis fascia as a grafting material.
METHODS: The records of 50 patients operated within the years 1999 and the 2004 were reviewed. TTMR with intact canal wall was performed in all cases. Both clinical and audiometric data were analyzed.
RESULTS: Overall perforation closure rate was 92%. There was no statistical significance in closure rate when grafting with AlloDerm versus temporalis fascia. A statistically significant shortened healing time was observed with AlloDerm grafting.
CONCLUSIONS: TTMR is a highly effective and safe technique.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15944563     DOI: 10.1016/j.otohns.2004.12.013

Source DB:  PubMed          Journal:  Otolaryngol Head Neck Surg        ISSN: 0194-5998            Impact factor:   3.497


  9 in total

1.  Treatment of Large Tympanic Membrane Perforations: Medial to Malleus Versus Lateral to Malleus.

Authors:  Erkan Kulduk; Rıza Dundar; Fatih Kemal Soy; Osman Kadir Guler; Ahmet Yukkaldiran; Ismail Iynen; Ferhat Bozkus
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2015-04-28

2.  A novel myringoplasty technique: the placement of a complementary graft descending from the scutum to support an anterosuperior perforation.

Authors:  Erdal Sakalli; Cengiz Celikyurt; Sultan Biskin; Selcuk Cem Erdurak
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-08-11       Impact factor: 2.503

3.  Hearing outcome after type I tympanoplasty: a retrospective study.

Authors:  Gaurav Batni; Rashmi Goyal
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2014-07-29

4.  The wheel-shaped composite cartilage graft (WsCCG) and temporalis fascia for type 1 tympanoplasty: a prospective, randomized study.

Authors:  Ejder Ciğer; Mustafa Koray Balcı; Akif İşlek; Kazım Önal
Journal:  Eur Arch Otorhinolaryngol       Date:  2018-10-13       Impact factor: 2.503

5.  Reconstruction of the abdominal wall by using a combination of the human acellular dermal matrix implant and an interpositional omentum flap after extensive tumor resection in patients with abdominal wall neoplasm: a preliminary result.

Authors:  Yan Gu; Rui Tang; Ding-Quan Gong; Yun-Liang Qian
Journal:  World J Gastroenterol       Date:  2008-02-07       Impact factor: 5.742

6.  Results of Acellular Dermis Matrix graft used for Tympanoplasty in Guinea pig model.

Authors:  Farhad Farahani; Alireza Karimi Yazdi; Mohammad Ghasemi; Elnaz Shariatpanahi; Abdol-Mohammad Kajbafzadeh; Saeid Amanpour
Journal:  Iran J Otorhinolaryngol       Date:  2015-03

7.  The influence of incudostapedial joint separation on the middle ear transfer function.

Authors:  Marcin Szymanski; Rafał Rusinek; Marek Zadrozniak; Kamal Morshed; Jerzy Warminski
Journal:  Clin Exp Otorhinolaryngol       Date:  2014-11-14       Impact factor: 3.372

Review 8.  [Regeneration - A New Therapeutic Dimension in Otorhinolaryngology].

Authors:  Nicole Rotter; Marcy Zenobi-Wong
Journal:  Laryngorhinootologie       Date:  2018-03-22       Impact factor: 1.057

9.  Evaluation of the organic and functional results of tympanoplasties through a retro-auricular approach at a medical residency unit.

Authors:  José Carlos Bolini de Lima; Silvio Antonio Monteiro Marone; Oswaldo Martucci; Fabiana Gonçalez; João Jovino da Silva Neto; Alice Carolina Mataruco Ramos
Journal:  Braz J Otorhinolaryngol       Date:  2011 Mar-Apr
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.